CombiMatrix logo

CBMX - CombiMatrix Share Price

$6.25 0.0  0.0%

Last Trade - 14/11/17

Micro Cap
Market Cap £n/a
Enterprise Value £n/a
Revenue £11.2m
Position in Universe th / 6849
Unlock CBMX Revenue
Relative Strength (%)
1m -21.6%
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2011 2012 2013 2014 2015 2016 2017E 2018E CAGR / Avg
4.66 5.35 6.37 8.04 10.1 12.9 16.0 19.2 +22.5%
Balance Sheet
FINANCIAL BRIEF: : For the nine months ended 30 September 2017,CombiMatrix Corp revenues increased 29% to $12M. Net lossapplicable to common stockholders decreased 71% to $1.5M.Revenues reflect an increase in demand for the Company'sproducts and services due to favorable market conditions.Lower net loss reflects Sales and marketing - Balancingvalue decrease of 15% to $3M (expense), Research anddevelopment decrease of 32% to $260K (expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History


CBMX Revenue Unlock CBMX Revenue

Net Income

CBMX Net Income Unlock CBMX Revenue

Normalised EPS

CBMX Normalised EPS Unlock CBMX Revenue

PE Ratio Range

CBMX PE Ratio Range Unlock CBMX Revenue

Dividend Yield Range

CBMX Dividend Yield Range Unlock CBMX Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
Net Profit
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2020 /  2021
CBMX EPS Forecasts Unlock CBMX Revenue
Profile Summary

CombiMatrix Corporation is a provider of molecular diagnostic solutions. The Company specializes in pre-implantation genetic screening, miscarriage analysis, prenatal diagnosis and pediatric developmental disorders, offering deoxyribonucleic acid-based testing for the detection of genetic abnormalities, which cannot be identified through traditional methodologies. It performs genetic testing utilizing a range of cytogenomic techniques, including chromosomal microarray analysis, fluorescence in situ hybridization and karyotyping. Its prenatal and postnatal microarray focuses on diagnosing genomic syndromes associated with intellectual disability, developmental delays, congenital anomalies, dysmorphic features and autism spectrum disorders. It develops and markets its molecular testing services in approximately four markets, such as in vitro fertilization (IVF), miscarriage analysis (products of conception analysis), prenatal genetics and postnatal developmental disorders.

Last Annual December 31st, 2016
Last Interim September 30th, 2017
Incorporated July 11, 2000
No. of Shareholders: 8
No. of Employees: 55
Sector Healthcare
Industry Healthcare Providers & Services
Exchange NASDAQ Capital Market
Shares in Issue 2,943,892
Free Float (0.0%)
Eligible for
CBMX Share Price Performance
Share Price
Bid - Ask
Low - High
Day's Change
Avg Volume
Open - Close
Range (12m)
Latest News for CBMX
Upcoming Events for CBMX
Frequently Asked Questions for CombiMatrix
What is the CombiMatrix share price?

As of 14/11/17, shares in CombiMatrix are trading at $6.25, giving the company a market capitalisation of £n/a. This share price information is delayed by 15 minutes.

How has the CombiMatrix share price performed this year?

Shares in CombiMatrix are currently trading at $6.25 and the price has moved by 0.184k% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the CombiMatrix price has moved by 94.3% over the past year.

What are the analyst and broker recommendations for CombiMatrix?

Of the analysts with advisory recommendations for CombiMatrix, there are there are currently 0 "buy" , 1 "hold" and 0 "sell" recommendations. The overall consensus recommendation for CombiMatrix is Hold. You can view the full broker recommendation list by unlocking its StockReport.

When will CombiMatrix next release its financial results?

CombiMatrix is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2018-09-30
What is the CombiMatrix dividend yield?

CombiMatrix does not currently pay a dividend.

Does CombiMatrix pay a dividend?

CombiMatrix does not currently pay a dividend.

When does CombiMatrix next pay dividends?

CombiMatrix does not currently pay a dividend.

How do I buy CombiMatrix shares?

To buy shares in CombiMatrix you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of CombiMatrix?

Shares in CombiMatrix are currently trading at $6.25, giving the company a market capitalisation of £n/a.

Where are CombiMatrix shares listed? Where are CombiMatrix shares listed?

Here are the trading details for CombiMatrix:

Country of listing: United States
Exchange: NAQ
Ticker Symbol: CBMX
What kind of share is CombiMatrix?

We were not able to load our ranking data for CombiMatrix

Is there a CombiMatrix share price forecast 2021?

We were not able to load any forecast data for CombiMatrix.

How can I tell whether the CombiMatrix share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like CombiMatrix. Over the past six months, the relative strength of its shares against the market has been -8.13%. At the current price of $6.25, shares in CombiMatrix are trading at % against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the CombiMatrix PE Ratio?

We were not able to find PE ratio data for CombiMatrix.

Who are the key directors of CombiMatrix?

We were unable to find the directors for CombiMatrix.

Who are the major shareholders of CombiMatrix?

Here are the top five shareholders of CombiMatrix based on the size of their shareholding:

Similar to CBMX
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.